<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
	<title>Reporting Bias</title>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<meta name="description" content="" />
	<meta name="keywords" content="" />
	<meta name="robots" content="index,follow" />
	<link rel="stylesheet" type="text/css" href="/openmetaanalysis.css" />
<meta name="author" content="openMetaAnalysis Contributors">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<script src="//code.jquery.com/jquery.min.js"></script>
<style>
.wrapper
{
  width: 860px;
  margin-top: 0px;
  margin-right: auto;
  margin-bottom: 0px;
  margin-left: auto;
}
/* Menu from http://codepen.io/philhoyt/pen/ujHzd */
#primary_nav_wrap
{
	margin-top:15px;
}
#primary_nav_wrap ul
{
	list-style:none;
	position:relative;
	float:left;
	margin:0;
	padding:0
}
#primary_nav_wrap ul a
{
	display:block;
	background-color:#6DC6E7;
	color:#FFFFFF;
	text-decoration:none;
	font-weight:bold;
	//font-weight:700;
	//font-size:12px;
	line-height:32px;
	padding:0 15px;
	//font-family:"HelveticaNeue","Helvetica Neue",Helvetica,Arial,sans-serif
}
#primary_nav_wrap ul li
{
	position:relative;
	float:left;
	margin:0;
	padding:0
}
#primary_nav_wrap ul li.current-menu-item
{
	background:#0022B4;
		color:#FFFFFF;
}
#primary_nav_wrap ul a:hover
{
	background:#0022B4;
	color:#FFFFFF;
}
#primary_nav_wrap ul ul
{
	display:none;
	position:absolute;
	top:100%;
	left:0;
	background-color:#6DC6E7;
	color:#FFFFFF;
	padding:0
}
#primary_nav_wrap ul ul li
{
	float:none;
	width:200px
}
#primary_nav_wrap ul ul a
{
	line-height:120%;
	padding:10px 15px;
}
#primary_nav_wrap ul ul ul
{
	top:0;
	left:100%
}
#primary_nav_wrap ul li:hover > ul
{
	display:block
}
.supsub {position: absolute}
.superscript {display:block; position:relative; left:2px; top: -2px; line-height: 30%}
.subscript   {display:block; position:relative; left:2px; top: 4px; line-height: 30%}
</style>
</head>

<body>
<!-- 
http://jquery-csv.googlecode.com/git/examples/basic-usage.html
http://jquery-csv.googlecode.com/git/examples/flot.html -> seems best and most stable without reticulating splines error
http://code.google.com/p/jquery-csv/wiki/API -> instructions
-->
<div class="wrapper">

<div class="page-header">
      <div style="color:#0022B4">
		<h1>openMetaAnalysis: <span style="font-size:50%">collaborative and continuous</span></h1>
	</div>
	
<nav id="primary_nav_wrap">
<ul id="menu">
<li class="listitem"><a href="http://openmetaanalysis.github.io/" class="menuitem">Home</a></li>
<li class="listitem"><a href="#" class="menuitem">Plot editors</a>
	<ul>
	<li><a href="/opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor.html" class="menuitem">Intervention</a></li>
	<li><a href="/opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor.html#instruct" class="menuitem">Intervention (instructional)</a></li>
	<li><a href="/opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor-dx.html" class="menuitem">Diagnosis</a></li>
	<li class="listitem"><a href="https://openmetaanalysis.ocpu.io/home/www/arrows.html" class="menuitem">Arrows Plot</a></li>
	</ul>
</li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/methods.html" class="menuitem">Methods</a></li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/new.html" class="menuitem">Create a new review</a></li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/update.html" class="menuitem">Improve/update an existing review</a></li>
</ul>
</nav>
</div>
<div style="clear:both">&nbsp;</div>
    <div class="wrapper">
      <header>
  <h1 style="color:#0022B4">Reporting Bias</h1>
       </header>
      <section>

<div>This page provides the details underpinning an example of reporting bias. This example focuses on one clinical recomendation, topical NSAIDs versus placebo for non-back pain over 1-7 days, from a larger, very well-done clinical practice guideline (PMID <a href="http://pubmed.gov/32805126">32805126</a>).  The goal of this example is to demonstrate the need for authors of guidelines and evidence syntheses to provide two rates that describe the possibility of publication bias their underlying evidence base:</div>
  <ul style="line-height:150%">
    <li>Registration rate of published subjects (RATE<span class='supsub'><sup class='superscript'>reg</sup><sub class='subscript'>pub</sub></span>)</li>
    <li>Publication rate of registered subjects (RATE<span class='supsub'><sup class='superscript'>pub</sup><sub class='subscript'>reg</sub></span>)</li>
  </ul>

<div>This example has been presented at the 2022 Annual Meeting of the Society of General Internal Medicine (see <a href="#notes">Notes</a> below).</div>

  <h2>Contents</h2>
  <ul>
    <li><a href="#section1">Registration rate of published subjects</a></li>
    <li><a href="#section2">Publication rate of subjects registered at ClinicalTrials.gov</a></li>
    <li><a href="#excluded">Excluded by APC from pairwise analysis but may be helpful</a></li>
  </ul>

<!-- **Edit here** -->
<h2 style="color:#0022B4" id="section1">Registration rate of published subjects</h2>
	<div>Total registered <i>and</i> published in 7 studies: 1316 = <span style='color:green;font-weight:bold'>314</span> + <span style='color:blue;font-weight:bold'>770</span> + <span style='color:black;font-weight:bold'>232</span></div>
	<div>Total published in ACP pairwise analysis for pain at 1-7 days (Supplement Table 14): 4777 subjects</div>
	<div>Rate of registration of published subjects: <b>28%</b> (1316/4777 subjects)</div>

<h3>ClinicalTrials.gov</h3>
	<div>Total registered <i>and</i> published in 2 studies: <span style='color:green;font-weight:bold'>314</span> = 242 + 72</div>
	<div>Total registered in 14 studies: 4101 subjects. The 14 includes the 11 trials listed as registered and ongoing at ClinicalTrials.gov in Appendix 2 of the ACP supplement plus 
	the first three studies below (Lau was found by the ACP and is in Appendix 2. Lau's results were not posted at the time of the ACP publication).</div>
<ul>
<ul>1. Predel HG, Hamelsky S, Gold M, Giannetti B.Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Med Sci Sports Exerc. 2012 PMID <a href="http://pubmed.gov/22525762">22525762</a>.<a href="https://clinicaltrials.gov/ct2/show/NCT00955513">NCT00955513</a></ul>
<ul>2. Predel HG, Giannetti B, Pabst H, Schaefer A, Hug AM, Burnett I. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study. BMC Musculoskelet Disord. 2013 PMID <a href="http://pubmed.gov/23964752">23964752</a>. <a href="https://clinicaltrials.gov/ct2/show/NCT01335724">NCT01335724</a><br/><br/></ul>
</ul>

<h3>EudraCT</h3>
	<div>Total registered <i>and</i> published in 4 studies: <span style='color:blue;font-weight:bold'>770</span> = 354+164+132+130</div>
<ul>
<ul>3. Hoffman P, Kopacka P, Gugliotta B, Rovati S. Efficacy and tolerability of DHEP-heparin plaster in reducing pain in mild-to-moderate muscle contusions: adouble-blind, randomized trial. Curr Med Res Opin. 2012 PMID <a href="http://pubmed.gov/22762346">22762346</a>. EudraCT <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2005-003829-31">2005-003829-31</a></ul>
<ul>4. Predel HG, Pabst H, Schafer A, Voss D, Giordan N. Diclofenac patch for the treatment of acute pain caused by soft tissue injuries of limbs: a randomized, placebo-controlled clinical trial. JSports Med Phys Fitness. 2016;56(1-2):92-9. EudraCT <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-020489-82">2005-003829-31</a></ul>
<ul>5. Predel HG, Connolly MP, Bhatt A, Giannetti B. Efficacy and safety assessment of acute sports-related traumatic soft tissue injuries using a new ibuprofen medicated plaster: results from arandomized controlled clinical trial. Phys Sportsmed. 2017 PMID <a href="http://pubmed.gov/28926295">28926295</a>; EudraCT <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-003257-29">2012-003257-29</a></ul>
<ul>6. Predel HG, Giannetti B, Connolly MP, Lewis F, Bhatt A. Efficacy and tolerability of a new ibuprofen 200mg plaster inpatients with acute sports-related traumatic blunt soft tissue injury/contusion.Postgrad Med. 2018 PMID <a href="http://pubmed.gov/29110567">29110567</a>. EudraCT <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-018018-21">2005-003829-31</a></ul>
</ul>
<h3>Hungarian National Institute of Health registry</h3>
	<div>Total registered <i>and</i> published in 1 study: <span style='color:black;font-weight:bold'>232</span></div>
<ul>
<ul>7. Predel HG, Giannetti B, Seigfried B, Novellini R, Menke G. A randomized,double-blind, placebo-controlled multicentre study to evaluate the efficacyand safety of diclofenac 4% spray gel in the treatment of acute uncomplicated anklesprain. J Int Med Res. 2013 PMID <a href="http://pubmed.gov/23908551">23908551</a>. Hungarian National Institute of Health registration 4526/40/98</ul>
</ul>

<!-- Publication rate of subjects registered at ClinicalTrials.gov-->
<h2 style="color:#0022B4" id="section2">Publication rate of subjects registered at ClinicalTrials.gov</h2>
	<div>Total published and registered in 2 studies: <span style='color:blue;font-weight:bold'>314</span></div>
	<div>Total registered in 13 studies: <!--4172 pre removing GSK and Lai-->3474 = <span style='color:green;font-weight:bold'>2889</span> + <span style='color:blue;font-weight:bold'>314</span> + <span style='color:black;font-weight:bold'>271</span></div>
	<div>Rate of publication of registered subjects: <b>9%</b> (314/3474 subjects)</div>

<h3>The CPG found that 11 trials registered at ClinicalTrials.gov but not published at the time of the ACP review (ACP Appendix 2)</h3>
<div>Subjects: <span style='color:green;font-weight:bold'>2889</span> (3202 [per studies in ACP Appendix 2] - 313 in GlaxoSmithKline)</div>
<div>These 11 trials include one trial that posted results the ACP search that indicate the study design is not relevant to our question:</div>
<ul>
<ul>1. GlaxoSmithKline. Voltaren Emulgel 2% Acute Ankle Sprain Non-Inferiority Study. 2019 (registered); 2022 (results posted) <a href="https://clinicaltrials.gov/ct2/show/NCT04052620">NCT04052620</a>) 313 subjects</ul>
</ul>

<div>The 10 remaining trials include a trial that posted <span style='color:red;font-weight:bold'>negative results</span> at ClinicalTrials.gov <i>after</i> the ACP search:</div>
<ul>
<ul>2. Lau H. Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain. 2014 (registered); 2020 (results posted) <span style='color:red;font-weight:bold'>PMID = NA (not published)</span> <a href="https://clinicaltrials.gov/ct2/show/NCT02324270">NCT02324270</a>)</ul>
</ul>
 
<h3>The CPG found and included two additional trials that were both registered at ClinicalTrials.gov and published.</h3>
<div>Subjects: <span style='color:blue;font-weight:bold'>314</span></div>
<ul>
<ul>1. Predel HG, Hamelsky S, Gold M, Giannetti B.Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Med Sci Sports Exerc. 2012 PMID <a href="http://pubmed.gov/22525762">22525762</a>. <a href="https://clinicaltrials.gov/ct2/show/NCT00955513">NCT00955513</a></ul>
<ul>2. Predel HG, Giannetti B, Pabst H, Schaefer A, Hug AM, Burnett I. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study. BMC Musculoskelet Disord. 2013 PMID <a href="http://pubmed.gov/23964752">23964752</a>. <a href="https://clinicaltrials.gov/ct2/show/NCT01335724">NCT01335724</a></ul>
</ul>

<h3>We found one additional registration that has not been published</h3>
<div>Subjects: <span style='color:black;font-weight:bold'>271</span></div>
<ul><ul>3. Hamelsky S. Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain. 2010 <span style='color:red;font-weight:bold'>PMID = NA (not published)</span> <a href="https://clinicaltrials.gov/ct2/show/NCT00573768">NCT00573768</a>. <span style='color:red;font-weight:bold'>Negative results</span>. Not found in ACP search.</ul>
</ul>

<div>Note:</div>
<ul>
<li>The 314 subjects were in the 2 trials (8% of registered subjects) that were published showed benefit of NSAIDs.</li>
<li>Two trials that were registered but not published posted <span style='color:red;font-weight:bold'>negative results</span> at ClinicalTrials.gov (Lau, 2014 <a href="https://clinicaltrials.gov/ct2/show/NCT02324270">NCT02324270</a>; Hamelsky, 2010 <a href="https://clinicaltrials.gov/ct2/show/NCT00573768">NCT00573768</a>)</li>
<li>The twelve registered trials without results were registered by industry between the years 2007 and 2019 (median year of registration 2009).</li>
</ul>


<h2 style="color:#0022B4" id="excluded">Excluded by APC from pairwise analyses but may be helpful</h2>
<ul>
<ul>1. Lai PM, Collaku A, Reed K. Efficacy and safety of topical diclofenac/menthol gel for ankle sprain: A randomized, double-blind, placebo- and active-controlled trial. J Int Med Res. 2017 PMID <a href="http://pubmed.gov/28345425">28345425</a>; <a href="https://clinicaltrials.gov/ct2/show/NCT02100670">NCT02100670</a>. NSAID not better than menthol, but ACP excluded as did not have true placebo.</ul>
<ul>2. Serinken M, Eken C, Elicabuk H. Topical Ketoprofen Versus Placebo in Treatment of Acute Ankle Sprain in the Emergency Department. Foot Ankle Int. 2016 PMID <a href="http://pubmed.gov/27198132">27198132</a>; <a href="https://clinicaltrials.gov/ct2/show/NCT02393846">NCT02393846</a>. NSAID superior at 30 minutes, but ACP excluded as did not report pain after 30 minutes.</ul>
</ul>

<h2 id="notes">Notes:</h2>
<div>This work was presented as a poster abstract at the 2022 Annual Meeting of the Society of General Internal Medicine:</div>
<div>&nbsp;</div>
<div>Badgett RG, Wissman K, Riaz IB, Bramley P, DeVito NJ. Can publication and selective reporting biases affect the recommendations of a well done clinical practice guideline? 2022 Annual Meeting of the Society of General Internal Medicine; 2022 April; Orlando, FL. J Gen Intern Med. 2022. doi: <a href="http://doi.org/10.1007/s11606-022-07653-8">10.1007/s11606-022-07653-8</a>. PMID: <a href="http://pubmed.gov/35713807">35713807</a>.</div>
</div>
<!-- Edit above this line -->
</section>
       
      <footer>
        <p>This project is maintained by <a href="http://openmetaanalysis.github.io/">openMetaAnalysis</a></p>
        <p><small>Hosted on GitHub Pages &mdash; Theme by <a href="https://github.com/orderedlist">orderedlist</a></small></p>

<div id="business"></div>
      </footer>

</div>
    <script src="javascripts/scale.fix.js"></script>
              <script type="text/javascript">
            var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
            document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
          </script>
          <script type="text/javascript">
            try {
              var pageTracker = _gat._getTracker("UA-56740469-1");
            pageTracker._trackPageview();
            } catch(err) {}
          </script>
<div id="tip" style="display:none"></div>
</body>
</html>
